At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 138 enrolled
Drug / intervention
Omega 3 (Fish Oil) Supplementation +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Omega-3 Dietary Supplementation, Immune Function, and Mood
In Brief
A Phase 2 clinical trial evaluating Omega 3 (Fish Oil) Supplementation and Placebo for Inflammation. Completed, enrolled 138 participants across 1 site.
Detailed Summary
This study is designed to examine the effects of fish oil on immune function and mood.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammation
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2006
First PostedOct 2006
Primary CompletionFeb 2011
TodayJul 2026
First PostedOct 11, 2006
Enrollment StartSep 1, 2006
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 19.7 years ago
Interventions
Omega 3 (Fish Oil) Supplementationdietary
1.25 g or 2.496 g daily for 4 months
Placebodietary
matching placebo capsule daily for 4 months